Deregulated Bone Morphogenetic Protein Receptor Signaling Underlies Fibrodysplasia Ossificans Progressiva

Author(s):
Gorter, D.J.J. de; Jankipersadsing, V.; Dijke, P. ten (0000-0002-2875-4723)
Published
2012
Publication type
Article / Letter to editor
BMPFibrodysplasia ossificans progressivaheterotopic ossificationactivin receptor-like kinase 2ALK2 R206Hosteoblast differentiation
Date issued
2012-09-30
Language
English
Is part of
Current Pharmaceutical Design (2012), Vol. 18, no. 27, p. 4087-4092
hdl
1887/118428
doi
10.2174/138161212802430495